<DOC>
	<DOCNO>NCT02131298</DOCNO>
	<brief_summary>This study design evaluate potential effect itraconazole pharmacokinetics palbociclib .</brief_summary>
	<brief_title>Effect Of Itraconazole On The Pharmacokinetics Of Palbociclib</brief_title>
	<detailed_description />
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<mesh_term>Palbociclib</mesh_term>
	<criteria>Healthy male and/or female subject nonchildbearing potential age 18 55 year , inclusive . Body mass index 17.5 30.5 kg/m2 , total body weight &gt; 50 kg ( 110 lb ) . Evidence personally sign date informed consent document indicate subject inform pertinent aspect study . Subjects willing able comply schedule visit , treatment plan , laboratory test , study procedure . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease . Any condition possibly affect drug absorption . A positive urine drug screen alcohol breath test . Pregnant female subject ; breast feed female subject , female subject childbearing potential , male subject partner currently pregnant , male subject childbearing potential unwilling unable use highly effective method contraception outline protocol duration study 90 day last dose investigational product .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Palbociclib</keyword>
	<keyword>Itraconazole</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Drug-Drug Interaction Study</keyword>
	<keyword>Healthy Volunteers</keyword>
</DOC>